Peptide Encyclopedia

Amyloid-beta peptide studied as a disease target and biomarker in Alzheimer's research. Investigated for cognition; preliminary evidence grade — no published interventional RCTs of administering it as a therapeutic.

Soluble activin type IIB receptor fusion protein studied for lean mass and metabolic health. One Phase I RCT showed increased lean mass in postmenopausal women; remaining evidence is preclinical. Flagged status, elevated risk.

Locally acting follistatin-based ligand trap investigated for lean mass in muscular dystrophy. Moderate evidence grade — two Phase 2 RCTs showed targeted muscle volume gains without significant functional improvement.

Endogenous adipose-derived hormone that regulates energy homeostasis and has anti-inflammatory properties. Studied as a biomarker and drug target for metabolic and cognitive conditions; preliminary evidence grade for administered use.

Peptidomimetic designed to target and apoptose white adipose tissue vasculature. Studied for metabolic health; preliminary evidence from obese primate models only — no human trials published. Flagged, elevated risk.

Tripeptide studied as its copper complex (AHK-Cu) for hair follicle and skin effects. Preliminary evidence — single ex-vivo/in-vitro study only, no human clinical trials published.

Copper complex of the alanyl-histidyl-lysine tripeptide studied for hair growth and skin effects. Preliminary evidence — a single ex-vivo follicle study; no published human clinical trials.

FDA-approved GLP-1 receptor agonist for type 2 diabetes management. Strong evidence grade — the Harmony Outcomes RCT demonstrated cardiovascular benefit. Approved status, low risk.

Synthetic HGH fragment studied for metabolic health and tissue recovery. Preliminary evidence — no published clinical trial data available in indexed literature.

Non-erythropoietic erythropoietin-derived peptide (cibinetide) investigated for neuropathic pain and tissue recovery. Limited evidence — a small human study in sarcoidosis neuropathy showed improved pain scores; remaining data are preclinical.

Topical cosmetic hexapeptide marketed for wrinkle reduction via neurotransmitter inhibition at skin level. Limited evidence grade — small human cosmetic studies show mixed results; supportive data are largely preclinical.

Single-chain relaxin-3/RXFP1 peptide agonist studied for metabolic and cardiorenal conditions. Preliminary evidence — early investigational stage with preclinical data.

Synthetic pentadecapeptide derived from a protective protein in gastric juice. Studied for soft-tissue and GI repair.

Short peptide studied for pulmonary and tissue recovery applications. Preliminary evidence — investigational stage with limited published human data.

Long-acting amylin analogue in late-clinical trials for metabolic health and weight management. Strong evidence grade from Phase 2/3 data; most studied in combination with semaglutide (cagrisema). Moderate risk.

Fixed-dose combination of cagrilintide (amylin analogue) and semaglutide (GLP-1 RA) in late-clinical trials for obesity and metabolic health. Strong evidence from Phase 3 trials showing substantial weight reduction. Low risk.

Short cardiac peptide studied for cardioprotection and tissue recovery. Preliminary evidence — investigational stage; published evidence is limited to preclinical models.

Short peptide studied for cartilage and connective tissue recovery. Preliminary evidence — investigational stage; evidence base is largely preclinical.

Porcine-derived neuropeptide mixture studied for neurological recovery and cognition. Moderate evidence from human trials in stroke and dementia; investigational status in most markets. Moderate risk.

Short tripeptide studied for lung and respiratory tissue recovery. Preliminary evidence — investigational stage; available data are preclinical or limited small-cohort studies.

Long-acting synthetic GHRH analogue studied for lean mass and longevity. Preliminary evidence — unapproved, elevated risk; one registered trial found, no peer-reviewed human efficacy data available.

CJC+DAC is catalogued in the Peptides Pub research index, with coverage focused on Lean mass.

COLLAGEN PEPTIDES is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery, Skin & hair.

CORTAGEN is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery.

DECAPEPTIDE-12 is catalogued in the Peptides Pub research index, with coverage focused on Skin & hair.

DEGARELIX is catalogued in the Peptides Pub research index, with coverage focused on Lean mass.

DEMOXYTOCIN is catalogued in the Peptides Pub research index, with coverage focused on Cognition & mood.

Dihexa is catalogued in the Peptides Pub research index, with coverage focused on Cognition & mood.

DSIP (Delta Sleep-Inducing Peptide) is catalogued in the Peptides Pub research index, with coverage focused on Cognition & mood.

DULAGLUTIDE is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

Epitalon is catalogued in the Peptides Pub research index, with coverage focused on Longevity & repair.

EXENATIDE is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health, Longevity & repair, Cognition & mood.

FOLLISTATIN 344 is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery.

FOXO4-DRI is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery, Skin & hair.

GDF-11 is catalogued in the Peptides Pub research index, with coverage focused on Longevity & repair.

Copper-binding tripeptide present in human plasma; extensive cosmetic literature, limited systemic data.

GHRELIN is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

GHRP-2 is catalogued in the Peptides Pub research index, with coverage focused on Lean mass.

GHRP-6 is catalogued in the Peptides Pub research index, with coverage focused on Lean mass.

GLP-1 is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

GONADORELIN is catalogued in the Peptides Pub research index, with coverage focused on Cognition & mood.

HCG is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

Hexarelin is catalogued in the Peptides Pub research index, with coverage focused on Lean mass.

HGH FRAGMENT 176-191 is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

HMG is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

HUMAN RELAXIN-2 is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery.

HUMANIN is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health, Longevity & repair, Cognition & mood.

Selective GHS-R agonist (ghrelin mimetic) that elicits a clean GH pulse without significant cortisol or prolactin rise.

Kisspeptin is catalogued in the Peptides Pub research index, with coverage focused on Cognition & mood.

KPV (LYS-PRO-VAL) is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery.

LANREOTIDE is catalogued in the Peptides Pub research index, with coverage focused on Cognition & mood.

LEUPROLIDE ACETATE is catalogued in the Peptides Pub research index, with coverage focused on Lean mass.

LINACLOTIDE is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

LIRAGLUTIDE is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

LL-37 is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery, Skin & hair.

Melanotan 1 is catalogued in the Peptides Pub research index, with coverage focused on Skin & hair.

Melanotan 2 is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

MODIFIED GRF 1-29 is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

MOTS-C is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

OCTREOTIDE is catalogued in the Peptides Pub research index, with coverage focused on Lean mass.

PASIREOTIDE is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

PINEALON is catalogued in the Peptides Pub research index, with coverage focused on Longevity & repair, Cognition & mood.

PLECANATIDE is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

PRAMLINTIDE is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

PROSTATILEN is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery.

PT-141 is catalogued in the Peptides Pub research index, with coverage focused on Cognition & mood.

Triple GIP/GLP-1/glucagon receptor agonist. Phase II data shows substantial weight reduction. Under investigation for metabolic disease.

RETINALAMIN is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery.

Synthetic heptapeptide analogue of tuftsin. Russian-developed anxiolytic with nootropic properties.

Long-acting GLP-1 receptor agonist with extensive Phase III and post-marketing data for type-2 diabetes and obesity.

Semax is catalogued in the Peptides Pub research index, with coverage focused on Cognition & mood.

Sermorelin is catalogued in the Peptides Pub research index, with coverage focused on Lean mass.

SS-31 is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health, Tissue recovery.

TB-500 is catalogued in the Peptides Pub research index, with coverage focused on Tissue recovery.

TEDUGLUTIDE is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

TESAMORELIN is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

THYMALIN is catalogued in the Peptides Pub research index, with coverage focused on Longevity & repair, Cognition & mood.

THYMOSIN ALPHA-1 is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health.

TIRZEPATIDE is catalogued in the Peptides Pub research index, with coverage focused on Metabolic health, Cognition & mood.

TRIPTORELIN is catalogued in the Peptides Pub research index, with coverage focused on Lean mass.

VILON is catalogued in the Peptides Pub research index, with coverage focused on Longevity & repair.

VIP PEPTIDE is catalogued in the Peptides Pub research index, with coverage focused on Cognition & mood.